Oncological outcomes and stoma-free survival following TaTME, a prospective cohort study

ConclusionsA local recurrence rate of 5.7% supports the oncological safety of TaTME for rectal cancer.
Source: Techniques in Coloproctology - Category: Surgery Source Type: research